Throughout this September, the Alzheimer's Association has been observing the inaugural World Alzheimer's Month. What better time to call on Congress to act!
More than 35 million people are living with dementia worldwide, including an estimated 5.4 million Americans. In addition, there are nearly 15 million unpaid dementia caregivers in the United States alone. World Alzheimer's Month is a time to applaud the everyday heroes facing Alzheimer's and fighting to overcome this disease. It's also a time to demand that Congress take action to improve the lives of those living with this disease and their families.
As an advocate, the most immediate way for you to take action is to ask your member of Congress to cosponsor the Health Outcomes, Planning, and Education (HOPE) for Alzheimer's Act (S.738/H.R. 1386). The HOPE for Alzheimer's Act will increase diagnosis of Alzheimer's disease and will ensure access to information, care and support for newly-diagnosed individuals and for their families. In short, this bill will provide essential support for those facing this devastating, debilitating disease.
Send a message to Congress. Let Congress know that we all have a part in the fight against this disease. Tell Congress to pass the HOPE for Alzheimer's Act.
First Meeting of the Federal Alzheimer's Advisory Council Announced
The first meeting of the Advisory Council on Alzheimer's Research, Care, and Services will be held on Tuesday, September 27, 2011. The Advisory Council was created by the National Alzheimer's Project Act (NAPA), which was unanimously passed by Congress last December and signed into law by the President in January. The Council will provide recommendations to the Secretary of Health and Human Services on what should go into a national Alzheimer's plan and how the federal government can do a better job of fighting this devastating disease.
Over the past few months, we've heard from thousands of Americans about what a national Alzheimer's plan should include. People with the disease, their caregivers, and their families and friends have shared their deeply personal and moving experiences as individuals affected by the disease. Whether the comments were provided on the NAPA website, at one of the in-person listening sessions around the country, or on the Association's nationwide "Tele-town Hall," one thing came through loud and clear: we need a stronger commitment from the federal government to fight this disease and care for those with it. We are truly grateful to all of you who weighed in for your courage and commitment to the cause. We will be providing all submitted comments and thoughts to the Administration and the Advisory Council later this fall.
Robert Egge
Vice President, Public Policy
Alzheimer's Association
When memory loss becomes a concernThe Miami Herald 09-12-11 Sept. 10--As greater awareness grows about Alzheimer's disease, fear of Alzheimer's is second only to cancer, according to a study this summer conducted by the Harvard School of Health. The concern is real, given that 5.4 million Americans are living with Alzheimer's and one in eight Americans aged 65 and older have the incurable memory disorder. So, when should you worry that you might have Alzheimer's? "That's a tough one," said Clinton Wright, scientific director of the McKnight Brain Institute at the University of Miami. He cites a joke about the husband who goes to the grocery store after he's given the order to buy some milk. He comes home and his wife asks, "Did you get the milk?" If his answer is that he simply forgot to buy the milk, and perhaps purchased other items, then this is probably not a problem. But if his response is, "What milk?" this could be a sign of mild cognitive impairment (MCI). Not everyone diagnosed with MCI goes on to develop Alzheimer's. However, those who do have MCI issues are at greater risk for developing Alzheimer's. "Normal aging in people is reaction time, things may slow down, what we call 'senior moments.' You're talking and you forget the name of someone and then it comes to you later. That's a normal type of aging. Maybe you don't calibrate things as quickly, but you do get there," said Dr. Allan Herskowitz, chief of neurology at Baptist Hospital. "In the last number of years it has really changed to what's considered normal memory loss from getting older and what would be thought of as an early dementia process, like Alzheimer's," said Dr. Elizabeth Crocco, medical director of the University of Miami's Memory Disorder Clinic. She cites an example. "If somebody had a long conversation with someone and totally forgot they had that conversation, or if a person repeats themselves a lot and there's a repeated pattern that interfered with their life, these are things we worry about." Symptoms of a more serious case of memory loss include headaches, poor speech syntax, a change in personal grooming habits and, often the earliest sign, a change in one's gait. "These are things we neurologists look for," Herskowitz said. "Those are pathological signs and could be a stroke, a tumor, or lots of things." Forgetting where you parked the car is often not cause for undue concern. You were probably distracted and simply not paying attention. "If you look back when you parked the car, you probably had a lot on your mind when you were walking from the car to the elevator. If you didn't pay attention, that's less worrisome. That's a natural inattention," said Wright. "A lot of memory lapses happen to a lot of people. If you're not paying attention to something, you're not going to remember it." If you are asking the same questions over and over or you get lost while driving a familiar route, these can be warning signs of abnormal memory issues and experts advise a visit to a doctor or specialist. Once there, patients can expect an in-depth consultation with a neurologist "that requires a lot of time where we sit and talk with people and get a good history before we jump to a test," Herskowitz said. One test, the Mini Mental Status Exam, is a 30-question test of generally simple questions such as, What's today's date? What season is it? How did you get here today? Basic mathematical calculations are included, such as, How much is seven from 100? Spatial tests call on a person to copy two images as well as write a sentence. Each question is worth one point. "Someone who gets 30/30, chances are it's not a problem while 20/30, that's a problem," Herskowitz said. These patients would undergo further neurological testing. "Eight out of 10 leave here reassured they are not suffering from Alzheimer's," Herskowitz said. ___ (c)2011 The Miami Herald Visit The Miami Herald at www.miamiherald.com Distributed by MCT Information Services *These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease.
|
Life Extension(R) Announces Recruitment for Alzheimer's Clinical Trial in South FloridaPRNewswire 08-25-11
FT. LAUDERDALE, Fla., Aug. 25, 2011 /PRNewswire/ -- Life Extension, a pioneer in the latest anti-aging research and integrative health therapies, while offering superior quality, research-backed dietary supplements, is actively recruiting participants for a free clinical trial to study the effects of natural supplements and an innovative medical therapy on Alzheimer's disease. Mild to moderate Alzheimer's patients (as diagnosed by their physician) are needed for a 17- to 18-week study. This study requires weekly visits to the office of the study's principal investigator located in the Fort Lauderdale area. Participants will receive blood tests, medical evaluations, blood pressure checks, and study medication and supplements at no cost. The objective of Life Extension's new clinical trial is to measure the effects of weekly injections of Enbrel(R) (generic name etanercept), a commonly used medication for autoimmune disorders such as rheumatoid arthritis, and nutritional supplements that may help suppress the inflammatory factor implicated in the neuronal degeneration of Alzheimer's disease. Twenty million Americans today are destined to contract Alzheimer's disease, an affliction that robs memory, intelligence and eventually the most rudimentary cognitive abilities. The few medications currently approved to treat Alzheimer's symptoms produce only modest, short-term effects. Some patients cannot tolerate them at all. Dr. Steven Hirsch, Director of Clinical Research at Life Extension, stated that "Up until now, a diagnosis of Alzheimer's disease meant one was destined to slowly be deprived of all cognitive function, a condition that tops the list of aging people's disease fears. This is the first clinical trial sponsored by Life Extension that will permit us to better understand Alzheimer's disease and how traditional medications, in conjunction with nutritional supplements, may affect its progress. We are seeking volunteers who meet the criteria for inclusion into the study in order to help future patients diagnosed with the disease." To participate in this study register online or send an e-mail expressing your interest in participating in this study to: LEClinicalResearch@LifeExtension.com. For further information you may also call the Life Extension Clinical Research Department at (866) 517-4536. About Life Extension For more than 30 years, Life Extension has been a pioneer in funding and reporting the latest anti-aging research and integrative health therapies while offering superior-quality dietary supplements to consumers. A trailblazer in the $26 billion U.S. dietary supplements industry, Life Extension's core mission is to extend the healthy human life span using an integrative approach and funding cutting-edge scientific research. For more information, visit www.lef.org, www.Twitter.com/LifeExtension, www.Facebook.com/LifeExtension and www.YouTube.com/LifeExtensionVideos. Contact:Jennifer NoelRF|Binder for Life Extension212-994-7502Jennifer.noel@rfbinder.com Life Extension Web site: www.lef.org/ Copyright PRNewswire 2011 |
|
Articles featured in Life Extension Daily News are derived from a variety of news sources and are provided as a service by Life Extension. These articles, while of potential interest to readers of Life Extension Daily News, do not necessarily represent the opinions nor constitute the advice of Life Extension. |